Fadi Khreish

15PUBLICATIONS
18CO-AUTHORS
Radiation therapyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 16, 2026
Outcome and safety of single-dose docetaxel-augmented targeted radionuclide therapy using [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy in treatment-refractory mCRPC: preliminary evidence from a pilot experience.

Niklas Ebert, Florian Rosar, Caroline Burgard

|Feb 24, 2026
Dosimetric analysis reveals rapid clearance and low absorbed dose of [¹⁷⁷Lu]Lu-PSMA-617 in non-prostate cancers with high PSMA expression.

Fadi Khreish, Florian Rosar, Caroline Burgard

|May 13, 2023
Tumor Sink Effect with Prostate-Specific Membrane Antigen-Targeted Theranostics in Patients with Metastatic Castration-Resistant Prostate Cancer: Intra-Individual Evaluations.

Caroline Burgard, Florian Rosar, Robert J Marlowe

|Mar 11, 2023
Detection Efficacy of 68Ga-PSMA-11 PET/CT in Biochemical Recurrence of Prostate Cancer with Very Low PSA Levels: A 7-Year, Two-Center "Real-World" Experience.

Caroline Burgard, Manuela A Hoffmann, Madita Frei

|Jan 08, 2023
PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study.

Amina Banda, Bastiaan M Privé, Youssra Allach

|Aug 26, 2022
Strongly Radioiodine-Positive Pancreatic Adenocarcinoma Mimicking Metastasis of Differentiated Thyroid Cancer.

Florian Rosar, Caroline Burgard, Maximilian Linxweiler

Pageof 3

Frequent Collaborators

12 joint publications

Samer Ezziddin

11 joint publications

Florian Rosar

7 joint publications

Caroline Burgard

5 joint publications

Mark Bartholomä